|
COX4I1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63358215843346E-12 |
| Normal-vs-Stage2 |
1.600260E-03 |
| Normal-vs-Stage3 |
8.185200E-04 |
| Normal-vs-Stage4 |
6.144400E-02 |
| Stage1-vs-Stage2 |
3.974600E-01 |
| Stage1-vs-Stage3 |
1.881830E-01 |
| Stage1-vs-Stage4 |
4.984400E-01 |
| Stage2-vs-Stage3 |
7.707400E-01 |
| Stage2-vs-Stage4 |
9.551800E-01 |
| Stage3-vs-Stage4 |
8.718400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
4.58519999968487E-07 |
| Normal-vs-Asian |
1.697810E-01 |
| Caucasian-vs-AfricanAmerican |
5.116800E-01 |
| Caucasian-vs-Asian |
2.665000E-01 |
| AfricanAmerican-vs-Asian |
4.038400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
2.14669999999417E-05 |
| Male-vs-Female |
3.004000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.76857999999447E-05 |
| Normal-vs-Extreme_Weight |
1.73183689611278E-12 |
| Normal-vs-Obese |
1.43450000000822E-06 |
| Normal-vs-Extreme_Obese |
1.011790E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.352200E-02 |
| Normal_Weight-vs-Obese |
8.112800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.917000E-01 |
| Extreme_Weight-vs-Obese |
6.356300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.089600E-01 |
| Obese-vs-Extreme_Obese |
4.151200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.660100E-02 |
| Normal-vs-Age(41-60Yrs) |
7.52630180400615E-11 |
| Normal-vs-Age(61-80Yrs) |
1.62525548574877E-12 |
| Normal-vs-Age(81-100Yrs) |
8.136600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.175400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.214970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.523600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.379540E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.224000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.151800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.59010000114301E-08 |
| Normal-VS-KIRP CIMP |
5.880200E-01 |
| Normal-VS-Unclassified PRCC |
9.79060000000365E-05 |
| Type1 PRCC-VS-Type2 PRCC |
6.333800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.279030E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.407000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.539100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.898600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.088100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.97309996014172E-09 |
| Normal-vs-N1 |
5.056300E-02 |
| Normal-vs-N2 |
6.354400E-01 |
| N0-vs-N1 |
4.361900E-02 |
| N0-vs-N2 |
1.489980E-01 |
| N1-vs-N2 |
7.207800E-01 |
|
|
